Nexalin Technology, Inc. (NXLIW)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -575.76 Thousand USD | -197.17% |
| 2022 | 592.51 Thousand USD | 214.71% |
| 2021 | 188.27 Thousand USD | -70.93% |
| 2020 | 647.57 Thousand USD | -16.31% |
| 2019 | 773.79 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -546.25 Thousand USD | 5.13% |
| 2024 Q2 | -848.79 Thousand USD | -55.38% |
| 2023 FY | -575.76 Thousand USD | -197.17% |
| 2023 Q2 | 298.76 Thousand USD | -18.83% |
| 2023 Q3 | 156.23 Thousand USD | -47.71% |
| 2023 Q1 | 368.06 Thousand USD | -37.88% |
| 2023 Q4 | -575.76 Thousand USD | -468.52% |
| 2022 Q2 | 514.7 Thousand USD | 33.1% |
| 2022 FY | 592.51 Thousand USD | 214.71% |
| 2022 Q1 | 386.71 Thousand USD | 105.4% |
| 2022 Q4 | 592.51 Thousand USD | 108.35% |
| 2022 Q3 | -7.09 Million USD | -1478.82% |
| 2021 Q1 | 78.43 Thousand USD | -87.15% |
| 2021 FY | 188.27 Thousand USD | -70.93% |
| 2021 Q4 | 188.27 Thousand USD | -64.36% |
| 2021 Q3 | 528.21 Thousand USD | 35.8% |
| 2021 Q2 | 388.96 Thousand USD | 395.9% |
| 2020 Q4 | 610.6 Thousand USD | 0.0% |
| 2020 FY | 647.57 Thousand USD | -16.31% |
| 2019 FY | 773.79 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 102.126% |
| BrainsWay Ltd. | -10.32 Million USD | 94.421% |
| Cerus Corporation | 84.35 Million USD | 100.683% |
| Envoy Medical, Inc. | -3.81 Million USD | 84.904% |
| electroCore, Inc. | -9.95 Million USD | 94.216% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 88.766% |
| IceCure Medical Ltd | -9.93 Million USD | 94.204% |
| Inogen, Inc. | -103.56 Million USD | 99.444% |
| OrthoPediatrics Corp. | -9.26 Million USD | 93.787% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 84.187% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 95.604% |
| MaxCyte, Inc. | -27.76 Million USD | 97.926% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 88.794% |
| Orthofix Medical Inc. | 96.44 Million USD | 100.597% |
| PAVmed Inc | 29.08 Million USD | 101.98% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 96.601% |
| RxSight, Inc. | -6.68 Million USD | 91.381% |
| Sight Sciences, Inc. | -102.71 Million USD | 99.439% |
| SI-BONE, Inc. | 5.72 Million USD | 110.064% |
| TELA Bio, Inc. | -3.94 Million USD | 85.42% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 101.004% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 263.57% |
| Acutus Medical, Inc. | 12.27 Million USD | 104.689% |
| Talis Biomedical Corporation | -57.06 Million USD | 98.991% |
| Spectral AI, Inc. | -3.5 Million USD | 83.554% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 98.801% |
| CVRx, Inc. | -59.95 Million USD | 99.04% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 129.018% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 145.065% |
| Bioventus Inc. | 372.51 Million USD | 100.155% |
| Venus Concept Inc. | 74.3 Million USD | 100.775% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 94.345% |
| LivaNova PLC | 62.53 Million USD | 100.921% |
| 908 Devices Inc. | -115.09 Million USD | 99.5% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.18% |
| Nemaura Medical Inc. | 9.92 Million USD | 105.801% |
| NeuroPace, Inc. | 54.33 Million USD | 101.06% |
| LENSAR, Inc. | -18.31 Million USD | 96.856% |
| Apyx Medical Corporation | -5.15 Million USD | 88.822% |
| Cutera, Inc. | 288.3 Million USD | 100.2% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 107.662% |
| BioSig Technologies, Inc. | 262 Thousand USD | 319.758% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 98.686% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 93.741% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.041% |
| Axonics, Inc. | -77.19 Million USD | 99.254% |
| Outset Medical, Inc. | 67.67 Million USD | 100.851% |
| IRIDEX Corporation | -4.28 Million USD | 86.573% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 99.677% |
| IRadimed Corporation | -47.71 Million USD | 98.793% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 80.973% |
| INVO Bioscience, Inc. | 8.45 Million USD | 106.813% |
| Telesis Bio, Inc. | 32.63 Million USD | 101.764% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 76.989% |
| Varex Imaging Corporation | 316.9 Million USD | 100.182% |
| Quipt Home Medical Corp. | 81.73 Million USD | 100.704% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 79.304% |
| Pulmonx Corporation | -42.36 Million USD | 98.641% |
| Dynatronics Corporation | 6.2 Million USD | 109.281% |
| Modular Medical, Inc. | -8.04 Million USD | 92.84% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 86.601% |
| Semler Scientific, Inc. | -57.13 Million USD | 98.992% |
| InMode Ltd. | -135.39 Million USD | 99.575% |
| Bruker Corporation | 891.3 Million USD | 100.065% |
| Cytosorbents Corporation | 4.18 Million USD | 113.768% |
| DexCom, Inc. | 2.02 Billion USD | 100.028% |
| Align Technology, Inc. | -840.47 Million USD | 99.931% |
| Viveve Medical, Inc. | -13.81 Million USD | 95.832% |
| ZimVie Inc. | 450.41 Million USD | 100.128% |
| Movano Inc. | -5.86 Million USD | 90.185% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 99.572% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -0.0% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 129.018% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.161% |
| Profound Medical Corp. | -18.17 Million USD | 96.833% |
| Insulet Corporation | 798.1 Million USD | 100.072% |
| enVVeno Medical Corporation | -2.21 Million USD | 74.041% |
| Surmodics, Inc. | -12.01 Million USD | 95.208% |
| iCAD, Inc. | -21.2 Million USD | 97.285% |
| Nuwellis, Inc. | -2.81 Million USD | 79.575% |
| Biotricity, Inc. | 23.09 Million USD | 102.493% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 100.615% |
| Aethlon Medical, Inc. | -4.5 Million USD | 87.21% |
| InspireMD, Inc. | -8.04 Million USD | 92.843% |
| PAVmed Inc. | 29.08 Million USD | 101.98% |
| BIOLASE, Inc. | 11.34 Million USD | 105.076% |
| Beyond Air, Inc. | 6.22 Million USD | 109.243% |
| FONAR Corporation | -14.66 Million USD | 96.074% |
| AxoGen, Inc. | 32.26 Million USD | 101.784% |
| Vivani Medical, Inc. | 42 Thousand USD | 1470.874% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 94.598% |
| Inari Medical, Inc. | -7.16 Million USD | 91.96% |
| UFP Technologies, Inc. | 40.77 Million USD | 101.412% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 118.763% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 87.933% |
| Tenon Medical, Inc. | -1.25 Million USD | 54.122% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 92.43% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 95.172% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.026% |
| Sintx Technologies, Inc. | 905 Thousand USD | 163.621% |
| NanoVibronix, Inc. | -3.27 Million USD | 82.435% |
| Quanterix Corporation | -132.95 Million USD | 99.567% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 79.304% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 97.426% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.076% |
| TransMedics Group, Inc. | 121.13 Million USD | 100.475% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 97.801% |
| NeuroMetrix, Inc. | -1.49 Million USD | 61.386% |
| Hyperfine, Inc. | -75.61 Million USD | 99.239% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 100.378% |
| Biomerica, Inc. | -3.38 Million USD | 82.991% |
| Bone Biologics Corporation | -3.02 Million USD | 80.976% |
| AVITA Medical, Inc. | -26.23 Million USD | 97.805% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 68.681% |
| Silk Road Medical, Inc | 64.42 Million USD | 100.894% |